Clinically important improvement thresholds for Harris Hip Score and its ability to predict revision risk after primary total hip arthroplasty

BMC Musculoskeletal Disorders

Volumn 17, Issue 1, 2016, Pages

  Singh, Jasvinder A ^a,b,c,d   Schleck, Cathy ^b   Harmsen, Scott ^b   Lewallen, David ^c  

^a and Clinical Center   (United States)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^c BIRMINGHAM VA MEDICAL CENTER   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Clinically important improvement; Discriminant ability; Harris Hip Score; MCID; MCII; Minimal clinically important difference; Minimal clinically important improvement; Predictability; Responsiveness; Total Hip Arthroplasty

Indexed keywords

ADULT; ARTICLE; CLINICALLY IMPORTANT IMPROVEMENT THRESHOLD; COHORT ANALYSIS; CONTROLLED STUDY; EFFECT SIZE; FEMALE; HARRIS HIP SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMAL CLINICALLY IMPORTANT IMPROVEMENT; MODERATE IMPROVEMENT; OUTCOME ASSESSMENT; PHYSICAL PARAMETERS; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE PERIOD; REOPERATION; STANDARDIZED RESPONSE MEAN; SURGICAL RISK; TOTAL HIP PROSTHESIS; TREATMENT RESPONSE; FOLLOW UP; HIP; HIP OSTEOARTHRITIS; HIP REPLACEMENT; MIDDLE AGED; PREDICTIVE VALUE; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; VALIDATION STUDY;

ARTHROPLASTY, REPLACEMENT, HIP; FEMALE; FOLLOW-UP STUDIES; HIP JOINT; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS, HIP; POSTOPERATIVE PERIOD; PREDICTIVE VALUE OF TESTS; PREOPERATIVE PERIOD; REOPERATION; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 84975476530     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/s12891-016-1106-8     Document Type: Article

References (26)

1. Healthcare Cost and Utilization Project (HCUP). HCUP Facts and Figures 2009- Section 3: Inpatient Hospital Stays by Procedure. Exhibit 3.1 Most Frequent All-listed Procedures. http://hcup-us.ahrq.gov/reports/factsandfigures/2009/pdfs/FF-2009-section3.pdf. Accessed 3 June 2016.
2. Report to the Chairman, Committee on Finance, U.S. Senate. Medicare. Lack of Price Transparency May Hamper Hospitals' Ability to Be Prudent Purchasers of Implantable Medical Devices. GAO-12-126. http://www.gao.gov/assets/590/587688.pdf. Accessed 3 June 2016.
3. Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg Am. 1969;51(4):737-55.
4. Riddle DL, Stratford PW, Singh JA, Strand CV. Variation in outcome measures in hip and knee arthroplasty clinical trials: a proposed approach to achieving consensus. J Rheumatol. 2009;36(9):2050-6.
5. Soderman P, Malchau H. Is the Harris hip score system useful to study the outcome of total hip replacement? Clin Orthop Relat Res. 2001;384:189-97.
6. Soderman P, Malchau H, Herberts P. Outcome of total hip replacement: a comparison of different measurement methods. Clin Orthop Relat Res. 2001;390:163-72.
7. Kavanagh BF, Fitzgerald Jr RH. Clinical and roentgenographic assessment of total hip arthroplasty. A new hip score. Clin Orthop Relat Res. 1985;193:133-40.
8. Wright JG, Young NL. A comparison of different indices of responsiveness. J Clin Epidemiol. 1997;50(3):239-46.
9. Shields RK, Enloe LJ, Evans RE, Smith KB, Steckel SD. Reliability, validity, and responsiveness of functional tests in patients with total joint replacement. Phys Ther. 1995;75(3):169-76. discussion 176-169.
10. Shi HY, Chang JK, Wong CY, Wang JW, Tu YK, Chiu HC, Lee KT. Responsiveness and minimal important differences after revision total hip arthroplasty. BMC Musculoskelet Disord. 2010;11:261.
11. Hoeksma HL, Van Den Ende CH, Ronday HK, Heering A, Breedveld FC. Comparison of the responsiveness of the Harris Hip Score with generic measures for hip function in osteoarthritis of the hip. Ann Rheum Dis. 2003;62(10):935-8.
12. Singh J, Sloan JA, Johanson NA. Challenges with health-related quality of life assessment in arthroplasty patients: problems and solutions. J Am Acad Orthop Surg. 2010;18(2):72-82.
13. Cohen J. A power primer. Psychol Bull. 1992;112(1):155-9.
14. Dworkin RH, Turk DC, McDermott MP, Peirce-Sandner S, Burke LB, Cowan P, Farrar JT, Hertz S, Raja SN, Rappaport BA, et al. Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations. Pain. 2009;146(3):238-44.
15. Singh JA, Schleck C, Harmsen WS, Lewallen D. Validation of the Mayo Hip Score: construct validity, reliability and responsiveness to change. BMC Musculoskelet Disord. 2016. (In Press).
16. Tubach F, Ravaud P, Baron G, Falissard B, Logeart I, Bellamy N, Bombardier C, Felson D, Hochberg M, van der Heijde D et al. Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement. Ann Rheum Dis. 2005;64(1):29-33.
17. Paulsen A, Roos EM, Pedersen AB, Overgaard S. Minimal clinically important improvement (MCII) and patient-acceptable symptom state (PASS) in total hip arthroplasty (THA) patients 1 year postoperatively. Acta Orthop. 2014;85(1):39-48.
18. Farrar JT, Young Jr JP, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94(2):149-58.
19. Singh JA, Yang S, Strand V, Simon L, Forsythe A, Hamburger S, Chen L. Validation of pain and patient global scales in chronic gout: data from two randomised controlled trials. Ann Rheum Dis. 2011;70(7):1277-81.
20. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, Katz LM, Lightfoot R, Jr., Paulus H, Strand V et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum. 1995;38(6):727-35.
21. Rothwell AG, Hooper GJ, Hobbs A, Frampton CM. An analysis of the Oxford hip and knee scores and their relationship to early joint revision in the New Zealand Joint Registry. J Bone Joint Surg Br. 2010;92(3):413-8.
22. Frihagen F, Grotle M, Madsen JE, Wyller TB, Mowinckel P, Nordsletten L. Outcome after femoral neck fractures: a comparison of Harris Hip Score, Eq-5d and Barthel Index. Injury. 2008;39(10):1147-56.
23. Huddleston JI, Wang Y, Uquillas C, Herndon JH, Maloney WJ. Age and obesity are risk factors for adverse events after total hip arthroplasty. Clin Orthop Relat Res. 2012;470(2):490-6.
24. Jimenez-Garcia R, Villanueva-Martinez M, Fernandez-de-Las-Penas C, Hernandez-Barrera V, Rios-Luna A, Garrido PC, de Andres AL, Jimenez-Trujillo I, Montero JS, Gil-de-Miguel A. Trends in primary total hip arthroplasty in Spain from 2001 to 2008: evaluating changes in demographics, comorbidity, incidence rates, length of stay, costs and mortality. BMC Musculoskelet Disord. 2011;12:43.
25. Kirksey M, Chiu YL, Ma Y, Della Valle AG, Poultsides L, Gerner P, Memtsoudis SG. Trends in in-hospital major morbidity and mortality after total joint arthroplasty: United States 1998-2008. Anesth Analg. 2012;115(2):321-7.
26. Wamper KE, Sierevelt IN, Poolman RW, Bhandari M, Haverkamp D. The Harris hip score: Do ceiling effects limit its usefulness in orthopedics? Acta Orthop. 2010;81(6):703-7.